Average Co-Inventor Count = 8.53
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cellular Biomedicine Group Hk Limited (6 from 7 patents)
2. Cellular Biomedicine Group, Inc. (4 from 4 patents)
3. Abelzeta Inc. (6 patents)
10 patents:
1. 11697848 - Reagent and method for fluorescence quantitative real-time PCR detection of RCL
2. 11633430 - Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
3. 11618778 - Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
4. 11608369 - Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
5. 11498973 - BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof
6. 11472858 - Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
7. 11439665 - Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
8. 11207349 - Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
9. 11142581 - BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof
10. 11066457 - Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof